EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET ANALYSIS

Market News

Key Developments

• In March 2020, Extracorporeal Shock Wave Lithotripsy (ESWL) was launched at M Yunus Regional Hospital in Benkulu, Indonesia in order to provide proper and improvised health services to the people of Bengkulu, Indonesia.
• In September 2019, Dornier MedTech, launched the new OptiVision technology for the Dornier Delta III, an extracorporeal shock wave lithotripsy (ESWL). The OptiVision is the first image processing software designed to increase the efficiency of kidney stone treatment, i.e., visualization of the steps of processing the kidney stone during the extracorporeal shock wave lithotripsy that may help in more successful treatment.
• In 2017, Dornier MedTech America, launched Delta III, an extracorporeal shock wave lithotripsy (ESWL), which is the modified version of Delta II. It is utilized for the treatment of kidney stone. Delta III has modified imaging, increased energy and efficiency over Delta II.
• In 2018, Stroz Medical and Seimens Healthlineers entered into a sale partnership agreement for the development of powerful extracorporeal shock wave lithotripsy (ESWL) technology. This technology are in development for the removal of stones from the entire urinary tract by combining the mobile C-arms technology in the Cios family